Democrats refuse to fix the health-care system, so the Republicans must, says Juliana Darrow. » Read More
By: Jake Novak
Here are three essential changes the GOP Senate health bill holdouts should demand for their votes, says Jake Novak. » Read More
By: Matthew Yglesias
The Senate's health bill fails traditional tests on rolling back public welfare programs. But it still has a solid shot, says Matt Yglesias. » Read More
By: Dan Mangan
Most Americans oppose moves that are key provisions in Republican-written bills that would repeal and replace major parts of Obamacare. » Read More
Mark Bertolini, Aetna chairman & CEO, shares his thoughts on the Affordable Care Act. You have to have a more affordable system, says Bertolini.
Mark Bertolini, Aetna chairman & CEO, discusses the company's quarterly results and the impact of the Affordable Care Act.
Insurance companies are hurting from the high cost of hepatitis C drug Sovaldi. Arthur Caplan, NYU Langone Medical Center, and CNBC's Bertha Coombs, share their opinions.
CNBC's Bertha Coombs reports which insurance stocks are hurting from the high cost of hepatitis C Sovaldi.
CNBC's Bertha Coombs reports which insurance stocks are feeling the pressure from high drug costs. FMHR trader Stephen Weiss advises investors to stick with Gilead.
Get the best of CNBC in your inbox